| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |